Management

  • David Campbell

    CEO

    30+-years’ experience across life-science, big-pharma, private-equity, strategic consulting and leading 8th spin-out.

    LinkedIn

  • William Scott

    CHIEF SCIENTIFIC OFFICER

    World-renowned transplant expert. Senior Lecturer and Faculty Theme Lead Regenerative Medicine, Stem Cells, and Transplantation, Newcastle University. Worked in UK/US transplant systems.

    LinkedIn

  • Martin Emms

    TECHNICAL DIRECTOR

    30+ years' experience developing safety-critical hardware/software solutions in highly-regulated industries.

    LinkedIn

  • Darren Kell

    OPERATIONS DIRECTOR

    20+ years’ experience in product development, scale-up and commercialisation across pharmaceuticals, medical devices and diagnostics.

    LinkedIn

  • Aqid Razzak

    DIRECTOR QA/RA

    Highly experienced quality manager. Experience working in range of industries including Medtech/Pharma.  covering required ISO/IEC standards.

    LinkedIn

  • Mark Horncastle

    INVESTOR DIRECTOR

    LinkedIn

Advisors

  • Reynolds M. Delgado

    Cardiologist at THI and  founder of Procyrion (Heart Assist Device)

  • Gabriel Loor, MD

    Director of lung transplantation in the division of cardiothoracic transplantation and circulatory support in the Michael E. DeBakey Department of Surgery

  • OH Frazier Jr MD

    Director of cardiovascular surgery research at the Texas Heart Institute (THI)

  • Syed B Peer

    Clinical Fellow, Baylor College of Medicine

  • Shannon Huff

    Med Tech Entrepreneur

  • Prof Derek Manas

    Consultant Hepatobiliary and Transplant Surgeon at Newcastle’s Institute of Transplantation and Organ and Tissue Donation and Transplantation (OTDT) Clinical Team for NHS-BT

  • Prof James Shaw

    Professor of Regenerative Medicine for Diabetes and Honorary Consultant Physician, Newcastle